REQUEST A DEMO
Total
USD $0.00
Search more companies

Sureste Efectclin S.A.S. (Ecuador)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: Sureste Efectclin S.A.S. Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Sureste Efectclin S.A.S. is a company based in Ecuador, with its head office in Quito. It operates in the Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) sector. The company was established on January 21, 2014. 5 (2023) employees currently work for Sureste Efectclin S.A.S.. Over the same period, its total assets decreased by 42.76%.

Headquarters
Isidro Otero N44-188
Quito; Pichincha;

Contact Details: Purchase the Sureste Efectclin S.A.S. report to view the information.

Website: http://www.sureste.org

Basic Information
Total Employees:
Purchase the Sureste Efectclin S.A.S. report to view the information.
Outstanding Shares:
Purchase the Sureste Efectclin S.A.S. report to view the information.
Registered Capital:
Purchase the Sureste Efectclin S.A.S. report to view the information.
Incorporation Date:
January 21, 2014
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
71.43%
Purchase this report to view the information.
14.29%
Purchase this report to view the information.
14.29%
Company Performance
Financial values in the chart are available after Sureste Efectclin S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net Profit (Loss) for the Period
N/A
Total assets
-42.76%
Total equity
577.25%
Return on Equity (ROE)
N/A

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?